je.st
news
Tag: cancer
GSK in $350 million deal to develop cancer drugs with UK biotech firm - FT
2014-06-02 06:25:29| Biotech - Topix.net
GlaxoSmithKline Plc has agreed a deal worth more than $350 million with UK biotech company Adaptimmune to develop cancer drugs, the Financial Times reported on Monday.
Tags: million
deal
firm
develop
Dutch Cancer Patients to Benefit from Erasmus Medical Center's New Treatment Technology
2014-06-02 06:00:00| Industrial Newsroom - All News for Today
Largest medical center in the Netherlands upgrades with several Elekta Versa HD linear accelerators<br /> <br /> ROTTERDAM, the Netherlands — Clinicians at the Erasmus University Medical Center (Erasmus MC) in Rotterdam, the Netherlands, will be able to offer patients the most modern cancer treatment available through its purchase of Elekta Versa HD™ linear accelerators (linacs) and a substantial software upgrade including Elekta's MOSAIQ® oncology information system and Monaco® 5 ...This story is related to the following:SoftwareSearch for suppliers of: Planning Software |
Tags: technology
medical
treatment
benefit
Doctors at Community Cancer Center Treat Inoperable Lung Cancer Using TrueBeam System for ...
2014-06-02 06:00:00| Industrial Newsroom - All News for Today
Newly installed technology enables clinicians to target lung and other tumors quickly and precisely using finely shaped radiation beams rather than surgery<br /> <br /> NORMAL, Ill. — When a diagnostic chest X-ray revealed a nodule on his left lung, Paul Hoffman, 79, had a biopsy and soon got bad news: it was Stage 1 lung cancer. He was given two options. The first was surgery, which would have been risky because Hoffman has a heart condition and a pacemaker. The second option was ...This story is related to the following:Radiotherapy Systems
Tags: for
system
community
center
CVAC Demonstrates Positive Trend in Overall Survival in Second Remission Ovarian Cancer
2014-06-02 02:51:01| Logistics - Topix.net
Prima BioMed Ltd is pleased to announce that CVac has demonstrated a positive trend in overall survival over standard of care in second remission ovarian cancer patients in the CAN-003 protocol.
Tags: positive
cancer
trend
survival
Quest Joins Memorial Sloan Kettering for Cancer Gene Tests
2014-06-02 02:15:49| Biotech - Topix.net
Quest Diagnostics Inc., the world's largest provider of medical testing services, will join with Memorial Sloan Kettering Cancer Center to screen patients' cancer genes and help doctors choose the best drugs.
Sites : [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] next »